1.Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer.
Dong HAN ; Ying WEI ; Xidi WANG ; Geng WANG ; Yinggang CHEN ;
Chinese Journal of Gastrointestinal Surgery 2017;20(1):62-66
OBJECTIVETo investigate the association of peripheral nerve invasion (PNI) with clinicopathological factors and prognosis of colorectal cancer.
METHODSClinicopathological data and Surgical specimens of 372 colorectal cancer patients who underwent radical resection from January 2011 to June 2012 in The Second Affiliated Hospital of Harbin Medical University were collected. Histopathological evaluation of tissue samples was conducted with hematoxylin and eosin-stained sections. PNI was considered positive when cancer cells were observed inside the nerve sheath, or when at least 33% of the nerve periphery was surrounded by cancer cells. The relationship between PNI and clinicopathological factors of colorectal cancer was analyzed by χtest or Fisher's exact test. Three-year overall survivals of PNI positive and negative patients were determined using the Kaplan-Meier method. Detection results were compared using log-rank test.
RESULTSOf 372 colorectal cancer patients, 133 (35.8%) were PNI positive. Among the PNI positive patients, 63 cases were male and 70 cases female; 76 cases were more than 60 years old and 57 cases less than 60 years old; tumors of 6 cases located in the ileocecal colon, of 33 cases in the ascending colon, of 7 cases in the transverse colon, of 8 cases in the descending colon, of 22 cases in the sigmoid colon, and of 57 cases in the rectum; tumor diameter was greater than 4 cm in 83 cases, and less than 4 cm in 50 cases; tumors of 48 cases were moderately or highly differentiated, and of 85 cases poorly-differentiation; tumor invasion depth in 2 cases, T2 in 7 cases, T3 in 93 cases, T4 in 31 cases; lymphatic metastasis was N0 phase in 56 cases, N1 in 41 cases, and N2 in 36 cases; tumors were stage I( in 2 cases, stage II( in 40 cases, of stage III( in 75 cases and stage IIII( in 16 cases. The positive rate of PNI was significantly associated with tumor location (χ=11.20, P=0.048), tumor size (χ=21.80, P=0.000), differentiation (χ=60.90, P=0.000), depth of invasion (χ=19.00, P=0.000), lymph node metastasis (χ=19.70, P=0.000) and TNM staging (χ=70.80, P=0.000), but not with sex, age or vascular invasion(P>0.05). The median follow-up time was 48 (8 to 62) months. Kaplan-Meier survival curve showed that the 3-year survival rate of PNI positive patients was 52.6%, significantly lower than that of PNI negative patients(78.3%, P=0.000). Further analysis of patients with stage II( and III( colorectal cancer showed that the 3-year survival rates of PNI positive patients were 62.3% and 43.5%, respectively, which were significantly lower than those of PNI negative patients with stage II( and III((91.7% and 79.4%), and the differences were statistically significant(P=0.000).
CONCLUSIONSPNI is a poor prognostic factor of colorectal cancer. It may be a complement of the classic TNM staging classification in stratifying colorectal cancer patients, especially in stages II( and III(.
Aged ; Colorectal Neoplasms ; diagnosis ; epidemiology ; mortality ; pathology ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Lymphatic Metastasis ; pathology ; Male ; Middle Aged ; Neoplasm Grading ; statistics & numerical data ; Neoplasm Invasiveness ; pathology ; physiopathology ; Neoplasm Staging ; statistics & numerical data ; Peripheral Nervous System Neoplasms ; mortality ; pathology ; Prognosis ; Retrospective Studies ; Risk Factors ; Survival Rate
2.OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.
Hua LI ; Qian MIAO ; Chun Wei XU ; Jian Hui HUANG ; Yue Fen ZHOU ; Mei Juan WU
Journal of Korean Medical Science 2016;31(8):1215-1223
Orthodenticlehomeobox 1 (OTX1) overexpression had previously been associated with the progression of several tumors. The present study aimed to determine the expression and role of OTX1 in human hepatocellular carcinoma (HCC). The expression level of OTX1 was examined by quantitative real-time PCR (qRT-PCR) in 10 samples of HCC and paired adjacent non-cancerous tissues, and by immunohistochemistry (IHC) analysis in 128 HCC samples and matched controls. The relationship between OTX1 expression and the clinicopathological features werealso analyzed. Furthermore, the effects of OTX1 knockdown on cell proliferation and migration were determined in HCC cell lines. Axenograft mouse model was also established to investigate the role of OTX1 in HCC tumor growth. TheqRT-PCR and IHC analyses revealed that OTX1 was significantly elevated in HCC tissues compared with the paired non-cancerous controls. Expression of OTX1 was positively correlated with nodal metastasis status (P = 0.009) and TNM staging (P = 0.001) in HCC tissues. In addition, knockdown of OTX1 by shRNA significantly inhibited the proliferation and migration, and induced cell cycle arrest in S phase in vitro. Tumor growth was markedly inhibited by OTX1 silencing in the xenograft. Moreover, OTX1 silencing was causable for the decreased phosphorylation level of ERK/MAPK signaling. In conclusion, OTX1 contributes to HCC progression possibly by regulation of ERK/MAPK pathway. OTX1 may be a novel target for molecular therapy towards HCC.
Aged
;
Animals
;
Blotting, Western
;
Carcinoma, Hepatocellular/metabolism/*pathology
;
Cell Line, Tumor
;
Cell Movement
;
Cell Proliferation
;
Disease Progression
;
Female
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Immunohistochemistry
;
Liver/metabolism/pathology
;
Liver Neoplasms/metabolism/*pathology
;
Lymphatic Metastasis
;
MAP Kinase Signaling System
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Mice, Nude
;
Middle Aged
;
Neoplasm Staging
;
Otx Transcription Factors/antagonists & inhibitors/genetics/*metabolism
;
Phosphorylation
;
RNA Interference
;
Real-Time Polymerase Chain Reaction
;
S Phase Cell Cycle Checkpoints
;
Transplantation, Heterologous
3.Carvenous lymphangioma of the vulva.
Kyung Ran YOON ; A Jin MO ; Sung Ho PARK ; Yeon Sik NA ; Sung Taek PARK
Obstetrics & Gynecology Science 2015;58(1):77-79
Lymphangioma is a rare proliferation of the lymphatic system which is classified as either lymphangioma circumscription or carvenous lymphangioma. The involvement of the vulva is very rare and only a small number of case reports have been made on carvenous lymphangioma of the vulva. We herein report a case of 20-year-old unmarried girl presented with gradually expanding and painless tumor of the left labium majus. The mass was removed surgically and pathology confirmed as carvenous lymphangioma, with no recurrences to date.
Female
;
Humans
;
Lymphangioma*
;
Lymphatic System
;
Pathology
;
Recurrence
;
Single Person
;
Vulva*
;
Vulvar Neoplasms
;
Young Adult
4.Current Status of Optical Imaging for Evaluating Lymph Nodes and Lymphatic System.
Eun Seong LEE ; Tae Sung KIM ; Seok Ki KIM
Korean Journal of Radiology 2015;16(1):21-31
Optical imaging techniques use visual and near infrared rays. Despite their considerably poor penetration depth, they are widely used due to their safe and intuitive properties and potential for intraoperative usage. Optical imaging techniques have been actively investigated for clinical imaging of lymph nodes and lymphatic system. This article summarizes a variety of optical tracers and techniques used for lymph node and lymphatic imaging, and reviews their clinical applications. Emerging new optical imaging techniques and their potential are also described.
Contrast Media/diagnostic use
;
Fluorescent Dyes/diagnostic use
;
Humans
;
Lymph Nodes/pathology/*radiography
;
Lymphatic System/*pathology
;
Lymphography
;
Magnetic Resonance Imaging
;
*Optical Imaging
;
Positron-Emission Tomography
;
Quantum Dots/diagnostic use
;
Spectroscopy, Near-Infrared
5.Lymph nodes distribution and metastatic pattern of ultra-low rectal cancer after neoadjuvant therapy.
Xue-feng GUO ; Lei WANG ; Zu-li YANG ; Liang KANG ; Teng-hui MA ; Jian-cong HU ; Yan-hong DENG ; Jian XIAO ; Jian-ping WANG
Chinese Journal of Gastrointestinal Surgery 2012;15(10):1053-1056
OBJECTIVETo investigate the lymph nodes distribution and metastatic pattern of the ultra-low rectal cancer after neoadjuvant therapy.
METHODSA total of 21 rectal cancer gross specimen after neoadjuvant therapy and 23 rectal cancer gross specimen without neoadjuvant therapy were investigated by whole mount section and tissue microarray techniques with CK20. All the patients were treated by abdominoperineal resection.
RESULTSThere were 138 lymph nodes retrieved from the mesorectum in the neoadjuvant group including 39 metastatic lymph nodes and 12 micro-metastatic lymph nodes. Among these nodes, there were 7 rectal cancer cases with lymph nodes and 2 cases with micro-metastatic lymph nodes, and 6 cases had pathological complete remission. There were 415 lymph nodes retrieved from the mesorectum in the group without neoadjuvant therapy including 169 metastatic lymph nodes and 59 micro-metastatic lymph nodes. Among these nodes, there were 12 rectal cancer cases with lymph nodes and 4 cases with micro-metastatic lymph nodes. The proportions of metastatic lymph nodes in outer zone between the two groups were 21.5% and 29.0%, and those in pre-zone were 17.6% and 17.2% respectively. The ratio of metastatic lymph nodes in ischiorectal fossa between the two groups were 25.0% vs. 22.2% respectively. The rate of metastatic or micro-metastatic lymph nodes cases between the two groups were 4.8% vs. 13.0% respectively.
CONCLUSIONSThe lymph nodes distribution and metastatic pattern of the ultra-low rectal cancer are affected by neoadjuvant therapy. The proportions of the anal sphincter invasion and metastatic or micro-metastatic lymph nodes in ischiorectal fossa are lower after neoadjuvant therapy. Abdominoperineal resection as the standard treatment of the ultra-low rectal cancer after neoadjuvant therapy should be re-evaluated.
Biopsy ; Digestive System Surgical Procedures ; Humans ; Lymph Nodes ; pathology ; Lymphatic Metastasis ; Neoadjuvant Therapy ; Rectal Neoplasms ; pathology ; therapy
6.Neuroendocrine neoplasm of digestive system with different grades: a clinicopathologic and prognostic study.
Ming-hui ZHANG ; Yan-hui LIU ; Xin-lan LUO ; Xing-tao LIN ; Heng-guo ZHUANG
Chinese Journal of Pathology 2012;41(7):448-451
OBJECTIVETo study the clinicopathologic and prognostic features of neuroendocrine neoplasm of digestive system with different grades.
METHODSThe clinicopathologic features of 139 cases of neuroendocrine neoplasm occurring in digestive system were retrospectively reviewed and graded according to the 2010 World Health Organization classification of tumours of the digestive system. Immunohistochemical study for synaptophysin, chromogranin A and Ki-67 was carried out. The follow-up and survival data were analysed using Kaplan-Meier method. Prognostic factors were tested by Log-rank testing and independent risk factors were analysed using Cox regression model.
RESULTSAmongst the 139 cases studied, there were 88 cases (63.3%) of grade 1 tumors, 9 cases (6.5%) of grade 2 tumors and 42 cases (30.2%) of grade 3 tumors. There was diffusely positive staining for synaptophysin and chromogranin A in most of the grade 1 and grade 2 tumors. The staining in grade 3 tumors however was focal (P < 0.05). The differences in tumor size, depth of invasion, presence of tumor emboli, perineural permeation, nodal involvement, distant metastasis and survival rate amongst the three groups was statistically significant (P < 0.05).
CONCLUSIONSThere is significant difference in the clinicopathologic and prognostic features of neuroendocrine neoplasm of digestive system with different grades. It is considered as an independent prognostic factor and represents a useful tool for prognostic evaluation of such tumors, both in clinical practice and research.
Adult ; Aged ; Aged, 80 and over ; Chromogranin A ; metabolism ; Digestive System Neoplasms ; metabolism ; pathology ; Female ; Follow-Up Studies ; Humans ; Ki-67 Antigen ; metabolism ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neoplastic Cells, Circulating ; Neuroendocrine Tumors ; metabolism ; pathology ; Proportional Hazards Models ; Retrospective Studies ; Survival Rate ; Synaptophysin ; metabolism ; Tumor Burden ; Young Adult
7.Expression of BRAF and its extracellular signal-regulated kinase 1/2 signal pathway in papillary thyroid cancer.
Wenjun YI ; Dewu ZHONG ; Qiongyan ZOU
Journal of Central South University(Medical Sciences) 2012;37(9):889-894
OBJECTIVE:
To determine the association between activity of BRAF and mitogen-activated protein/ extracellular signal-regulated kinase kinase (MEK) / extracellular signal-regulated kinase (ERK) signal pathway in papillary thyroid cancer and its mechanism.
METHODS:
We collected the clinical data and blood samples from 73 cases of papillary thyroid cancer and another 16 cases of benign thyroid gland tumor, and detected the expression of rat sarcoma (RAS), BRAF, MEK1/2, and ERK1/2 in all tumor specimens and benign thyroid tissues with immunohistochemistry and Western blot.
RESULTS:
The expression of RAS, BRAF, pMEK1/2, and pERK1/2 protein in papillary thyroid cancer tissues was higher than those in the benign thyroid tissues(P<0.05 or P<0.01). The expression of RAS, BRAF, MEK1/2, and ERK1/2 was associated with the tumor size, the lymph node metastasis, and the clinical stage of papillary thyroid cancer(P<0.05 or P<0.01).
CONCLUSION
The expression of RAS, BRAF, pMEK1/2, and pERK1/2 is associated with the pathogenesis, the lymph node metastasis, and the clinical stage of papillary thyroid cancer. The MEK/ERK signaling pathway may be activated by BRAF in papillary thyroid cancer.
Adult
;
Aged
;
Carcinoma, Papillary
;
genetics
;
metabolism
;
pathology
;
Female
;
Humans
;
Lymphatic Metastasis
;
MAP Kinase Signaling System
;
Male
;
Middle Aged
;
Mitogen-Activated Protein Kinase 1
;
genetics
;
metabolism
;
Mitogen-Activated Protein Kinase 3
;
genetics
;
metabolism
;
Proto-Oncogene Proteins B-raf
;
genetics
;
metabolism
;
Thyroid Neoplasms
;
genetics
;
metabolism
;
pathology
;
Young Adult
;
ras Proteins
;
genetics
;
metabolism
8.Experience of laparoscopic total mesorectal excision for middle or low rectal cancer.
Hai QIN ; Xi-peng ZHANG ; Yi ZHOU ; Hui-chen LI ; Tao LI
Chinese Journal of Oncology 2010;32(2):156-157
OBJECTIVETo study the feasibility and safety of laparoscopic surgery for middle or low rectal cancer.
METHODS83 patients with middle or low rectal cancer received laparoscopic surgery and 85 patients received conventional open surgery. The cutting edge of specimens and number of lymph nodes were analyzed retrospectively.
RESULTSThe mean distance between resected margin and the tumor was 3.21 +/- 1.25 cm in laparoscopic operation group, while it was 1.15 +/- 1.11 cm in the open surgery group (P = 0.001). The mean number of disected lymph nodes was 12.53 +/- 1.88 in the laparoscopic operation group and 10.85 +/- 1.81 in the open operation group (P = 0.01). The incidence of postoperative complications was 12.0% in the laparoscopic operation group and 23.5% in the open operation group (P = 0.026). The mean time of food intake and using analgesics after surgery were 2.43 +/- 1.06 days and 2.53 +/- 1.01 days, respectively, in the laparoscopic operation group, while the corresponding figures were 3.67 +/- 1.13 days and 4.55 +/- 1.78 days, respectively, in the open operation group (P = 0.005, P = 0.008).
CONCLUSIONLaparoscopic surgery is a safe and effective procedure for middle or low rectal cancer, with less postoperative complications and better recovery after treatment.
Adult ; Aged ; Aged, 80 and over ; Digestive System Surgical Procedures ; methods ; Female ; Humans ; Laparoscopy ; methods ; Lymph Node Excision ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Postoperative Complications ; Rectal Neoplasms ; surgery ; Rectum ; pathology ; surgery ; Young Adult
9.Expression features of P-glycoprotein, glutathione S transferase-pi and inhibitor of apoptosis proteins in lymph node metastases of gastrointestinal carcinomas.
Jie HAN ; Bi-bo TAN ; An-feng WANG ; Bing-rong LÜ ; Wei GENG ; Jian-hui ZHAO ; Chun-nian HE
Chinese Journal of Surgery 2009;47(2):106-108
OBJECTIVETo investigate the expression features of P-glycoprotein (P-gp), glutathione S transferase-pi (GST-pi) and inhibitor of apoptosis proteins like p53, survivin and bcl-2 in lymph node metastases of gastrointestinal carcinomas.
METHODSThe expression of P-gp, GST-pi, p53, survivin and bcl-2 were determined by using immunohistochemistry technique in surgical specimens of primary tumor (PT) and lymph node metastases (LNMs) from 54 gastrointestinal cancer patients with metastasis of lymph nodes. The expression difference of 5 multi-drug resistance (MDR)-related factors between LNMs and PT were compared.
RESULTSSignificant difference was found in the expression of P-gp and GST-pi between the two groups (both P < 0.05), and expression of p53 and bcl-2 showed positive correlation between LNMs and PT (r = 0.7248, 0.5524; both P < 0.05), respectively. In LNMs, P-gp expression was positively correlated with GST-pi (r = 0.4062, P < 0.05) and survivin (r = 0.6169, P < 0.05), and also GST-pi expression was related positively with survivin (r = 0.4027, P < 0.05). Statistically positive correlations were noted between bcl-2 and P-gp (r = 0.3986, P < 0.05), bcl-2 and survivin (r = 0.2937, P < 0.05), as well as GST-pi and survivin (r = 0.4481, P < 0.01) in PT. Only a positive correlation between GST-pi and survivin expression was simultaneously shown in both LNMs and PT.
CONCLUSIONSThere is significant heterogeneity of MDR-related factors expression in LNMs of gastrointestinal carcinomas. Effective adjuvant chemotherapy after operation should target on the metastatic loci of the disease.
ATP-Binding Cassette, Sub-Family B, Member 1 ; metabolism ; Adult ; Aged ; Aged, 80 and over ; Digestive System Neoplasms ; metabolism ; pathology ; Female ; Glutathione S-Transferase pi ; metabolism ; Humans ; Inhibitor of Apoptosis Proteins ; Lymph Nodes ; metabolism ; pathology ; Lymphatic Metastasis ; Male ; Microtubule-Associated Proteins ; metabolism ; Middle Aged ; Proto-Oncogene Proteins c-bcl-2 ; metabolism ; Tumor Suppressor Protein p53 ; metabolism
10.Effect of mesenteric lymphatic duct ligation on the system inflammation during the intestinal ischemia-reperfusion.
Gui-zhen HE ; Liang-guang DONG ; Xiao-yu CUI ; Xue-feng CHEN ; Hong SHU
Chinese Journal of Gastrointestinal Surgery 2008;11(5):469-471
OBJECTIVETo estimate the effect of the lymph duct ligation on systemic inflammatory factors and endotoxins during intestinal ischemia-reperfusion (I/R).
METHODSMale SD rats underwent occlusion of superior mesenteric artery for 60 min followed by reperfusion for 120 min plus lymph duct ligation or not. Forty rats were randomly divided into 4 groups: group A (blank); group B (sham); group C (intestinal I/R); group D (intestinal I/R plus lymph duct ligation). Mesenteric lymph nodes were harvested for standard bacteriologic cultures. The endotoxin, D-lactate, diamine oxidase (DAO), and cytokines in serum were detected.
RESULTSThe rates of bacterial translocation to mesenteric lymph nodes were 40% in group C and 20% in group D. No positive lymph node cultures were encountered in any of group A and B. The serum cytokines (except for sICAM-1) , D-lactate, DAO and endotoxin levels were lower in group D than those in group C (P<0.05), but both were higher than those in group A and B (P<0.05).
CONCLUSIONDuring intestinal I/R injury, blockage the lymph flow from gut into bloodstream decreases the levels of cytokines, and significantly attenuates the increase in intestinal permeability.
Animals ; Disease Models, Animal ; Inflammation ; Intestinal Diseases ; metabolism ; microbiology ; pathology ; Intestines ; blood supply ; pathology ; Ligation ; Lymph Nodes ; pathology ; Lymphatic System ; surgery ; Male ; Rats ; Rats, Sprague-Dawley ; Reperfusion Injury ; metabolism ; microbiology ; pathology

Result Analysis
Print
Save
E-mail